This medical device maker, known for MRI-compatible equipment, reported a notable insider sale amid strong one-year stock performance.
ORLANDO, Fla., May 20, 2026 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD), a leader in developing innovative MRI-compatible medical devices, today announced that Roger Susi, President and Ch

Why Iradimed Stock Topped the Market Today

07:48pm, Friday, 01'st May 2026
Yet again, it posted growth and robust profitability in its latest quarter.
On May 01, 2026, iRadimed Corp (IRMD) shares rose 4.4%, bringing the current price to $87.15. This movement comes amid a 52-week range that has seen a high of $
IRADIMED CORPORATION (IRMD) Q1 2026 Earnings Call Transcript
iRadimed (IRMD) came out with quarterly earnings of $0.49 per share, beating the Zacks Consensus Estimate of $0.45 per share. This compares to earnings of $0.42 per share a year ago.
Announces Regular Quarterly Cash Dividend of $0.20 Per Share Reaffirms Full-Year 2026 Revenue and Earnings Guidance  Reports revenue of $22.0 million for the first quarter of 2026, an increase of $2.
ORLANDO, Fla., April 27, 2026 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2026 first quarter financial results before the market opens on
ORLANDO, Fla., April 10, 2026 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) today announced that it will participate in the 25th Annual Needham Virtual Healthcare Conference.
iRadimed Corporation (NASDAQ: IRMD - Get Free Report) CEO Roger Susi sold 5,000 shares of iRadimed stock in a transaction on Monday, April 6th. The shares were sold at an average price of $96.02, for
iRadimed Corporation (NASDAQ: IRMD - Get Free Report) CEO Roger Susi sold 5,000 shares of the stock in a transaction that occurred on Monday, March 23rd. The stock was sold at an average price of $100
GMED, TCMD and IRMD tap GenAI to boost diagnostics and workflows, but high costs, regulation gaps and macro pressures still weigh on MedTech growth.
ORLANDO, Fla., March 16, 2026 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) today announced that it will participate in the 38 th Annual Roth Conference.
ISRG, GMED, EW, ALC and IRMD show strong short-term upside as AI tools, acquisitions and new product pipelines fuel growth.
Principal Financial Group Inc. bought a new position in iRadimed Corporation (NASDAQ: IRMD) in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC).
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE